Researchers developed a novel hybrid nanoparticle using a Layer-by-Layer (method for siRNA delivery targeting eukaryotic elongation factor 2 kinase (eEF2K) in TNBC.
[Drug Delivery and Translational Research]
Development of Silver-Based Hybrid Nanoparticles Loaded with eEF2 K-siRNA and Quercetin against Triple-Negative Breast Cancer
